サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542698

クリティカルケア診断薬の世界市場

Critical Care Diagnostics

出版日
ページ情報
英文 256 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
クリティカルケア診断薬の世界市場
出版日: 2024年08月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 256 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

クリティカルケア診断薬の世界市場は2030年までに20億米ドルに到達

2023年に14億米ドルと推定されるクリティカルケア診断薬の世界市場は、分析期間2023-2030年にCAGR 5.8%で成長し、2030年には20億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである免疫タンパク質は、CAGR 4.8%を記録し、分析期間終了時には7億1,350万米ドルに達すると予測されます。ルーチン＆特殊化学分野の成長率は、分析期間中CAGR 8.5％と推定されます。

米国市場は推定3億5,470万米ドル、中国はCAGR9.0%で成長予測

米国のクリティカルケア診断薬市場は、2023年に3億5,470万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 9.0%で推移し、2030年には4億6,670万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3%と4.6%と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界のクリティカルケア診断薬市場- 主要動向と促進要因のまとめ

ヘルスケアのライフラインの次は？クリティカルケア診断薬の台頭

クリティカルケア診断薬は、集中治療室（ICU）や救急部における患者の管理・治療において極めて重要です。これらの診断法は、迅速で正確な結果を提供する迅速検査プラットフォームに重点を置いており、生命を脅かす状況下で即座の臨床判断を可能にします。代表的な検査には、血液ガス分析、電解質検査、心臓マーカー、凝固検査、感染症のバイオマーカーなどがあります。これらの検査は、リアルタイムで治療方針に影響を与え、患者の転帰に劇的な影響を与えることが多いため、そのスピードと精度は極めて重要です。クリティカルケア診断薬の使用は、即時の介入にとどまらず、継続的な治療効果のモニタリングや、クリティカルケア環境における患者の状態の変化に応じてプロトコルを調整するのにも役立ちます。

技術革新はどのようにクリティカルケア診断薬を形成していますか？

クリティカルケア診断薬の情勢は、技術の進歩によって絶えず変化しています。自動化は多くのICUの基礎となっており、複数のサンプルを処理し、最小限の手作業で結果を出すように設計されています。POC（ポイント・オブ・ケア）機器も大きな技術革新を遂げました。これらのコンパクトで携帯可能な機器は、ベッドサイドで様々な診断を行うことができ、集中ラボへのサンプル搬送の必要性を減らし、ケアプロセスをスピードアップします。さらに、診断機器にデジタルツールや人工知能を統合することで、データ分析が強化され、複雑なデータセットや経時的動向をより正確に解釈できるようになっています。これらの技術的進歩は、診断プロセスの効率を向上させるだけでなく、重要な状況においてより高い精度を保証します。

先進的クリティカルケア診断薬の導入に影響を与える課題とは？

明確な利点があるにもかかわらず、先進的なクリティカルケア診断薬の採用にはいくつかの課題があります。特に資源不足の環境や発展途上国では、最先端の診断機器の高コストが大きな障壁となります。また、新技術を効果的に操作・維持するための医療従事者のトレーニングの問題もあり、これには時間と資源がかかります。さらに、新しい診断ツールを既存のヘルスケアITシステムに統合するには、互換性とデータ管理の課題があります。これらのシステムの相互運用性を確保し、患者データの完全性とセキュリティを維持することは極めて重要ですが、シームレスに実現することはしばしば困難です。

クリティカルケア診断薬市場の成長の原動力は？

クリティカルケア診断薬市場の成長は、慢性疾患の世界の罹患率の増加や、緊急時にタイムリーで正確な結果をもたらす迅速な診断方法に対する需要の高まりなど、いくつかの要因によってもたらされます。また、世界の高齢化も、高齢者が重篤な治療を必要とする急性疾患に罹患しやすいことから、この市場の成長に寄与しています。新たな機能を提供し、既存の診断プロセスを改善する技術の進歩は絶えず現れており、この分野への関心と投資をさらに刺激しています。さらに、高度な診断ツールを備えたICU病床数や救急専門病棟の増加など、世界のヘルスケアインフラの拡大も市場の拡大を後押ししています。ヘルスケアシステムが死亡率の低減と重要な環境におけるケア水準の向上にますます重点を置くようになるにつれ、高度なクリティカルケア診断薬に対する需要は増加の一途をたどっており、現代医療におけるクリティカルケア診断薬の重要な役割が浮き彫りになっています。

調査対象企業の例（全103件）

  • Abbott Laboratories
  • Alere, Inc.
  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biosensors Japan Co., Ltd.
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings PLC
  • Nanomix, Inc.
  • Nova Biomedical Corporation
  • Roche Diagnostics（Schweiz）AG
  • Siemens Healthineers
  • Sysmex Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP11367

Global Critical Care Diagnostics Market to Reach US$2.0 Billion by 2030

The global market for Critical Care Diagnostics estimated at US$1.4 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Immunoproteins, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$713.5 Million by the end of the analysis period. Growth in the Routine & Special Chemistry segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$354.7 Million While China is Forecast to Grow at 9.0% CAGR

The Critical Care Diagnostics market in the U.S. is estimated at US$354.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$466.7 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Critical Care Diagnostics Market - Key Trends and Drivers Summarized

What's Next in the Lifeline of Healthcare? The Rise of Critical Care Diagnostics

Critical care diagnostics are pivotal in the management and treatment of patients in intensive care units (ICUs) and emergency departments. These diagnostics focus on rapid testing platforms that deliver quick, accurate results, enabling immediate clinical decisions during life-threatening situations. Typical tests include blood gas analysis, electrolyte testing, cardiac markers, coagulation testing, and biomarkers for infection. The speed and accuracy of these tests are crucial, as they often influence treatment directions in real-time, dramatically impacting patient outcomes. The use of critical care diagnostics extends beyond immediate interventions, helping to monitor ongoing treatment effectiveness and adjust protocols as patients' conditions evolve within critical care settings.

How Are Technological Innovations Shaping Critical Care Diagnostics?

The landscape of critical care diagnostics is continually transformed by technological advancements. Automation has become a cornerstone in many ICUs, with systems designed to handle multiple samples and deliver results with minimal manual intervention. Point-of-care (POC) devices have also seen significant innovation; these compact, portable devices can perform a range of diagnostics at the bedside, reducing the need to transport samples to centralized labs and thus speeding up the care process. Additionally, the integration of digital tools and artificial intelligence in diagnostics equipment is enhancing data analysis, enabling more precise interpretations of complex datasets and trends over time. These technological advancements not only improve the efficiency of diagnostic processes but also ensure greater accuracy in critical situations.

What Challenges Impact the Adoption of Advanced Critical Care Diagnostics?

Despite the clear benefits, the adoption of advanced critical care diagnostics faces several challenges. The high cost of cutting-edge diagnostic equipment can be a significant barrier, especially in under-resourced settings or developing countries. There is also the issue of training medical personnel to operate and maintain new technologies effectively, which can be time-consuming and resource-intensive. Additionally, the integration of new diagnostic tools into existing healthcare IT systems poses compatibility and data management challenges. Ensuring that these systems are interoperable and that they maintain the integrity and security of patient data is crucial but often difficult to achieve seamlessly.

What Are the Driving Forces Behind the Growth in the Critical Care Diagnostics Market?

The growth in the critical care diagnostics market is driven by several factors, beginning with the increasing global incidence of chronic diseases and the rising demand for rapid diagnostic methods that can deliver timely and precise results in emergency situations. The aging population worldwide also contributes to this growth, as older adults are more prone to acute events that require critical care. Technological advancements that offer new capabilities and improve existing diagnostic processes are continually emerging, further stimulating interest and investment in this sector. Additionally, the expansion of healthcare infrastructure globally, including the increase in the number of ICU beds and specialized emergency units equipped with advanced diagnostic tools, supports market expansion. As healthcare systems increasingly focus on reducing mortality and improving care standards in critical settings, the demand for sophisticated critical care diagnostics continues to rise, underscoring their essential role in modern medicine.

Select Competitors (Total 103 Featured) -

  • Abbott Laboratories
  • Alere, Inc.
  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biosensors Japan Co., Ltd.
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings PLC
  • Nanomix, Inc.
  • Nova Biomedical Corporation
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers
  • Sysmex Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Critical Care Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Chronic Conditions Drives Demand for Critical Care Diagnostics
    • Technological Advancements in Point-of-Care Diagnostics Enhance Critical Care
    • Growing Need for Rapid Diagnostic Techniques in Emergency Rooms
    • Integration of Telemedicine and Remote Monitoring in Critical Care Settings
    • Expansion of Healthcare Infrastructure Globally Bolsters Diagnostics Market
    • Aging Population and Increased Susceptibility to Acute Conditions Propel Market Growth
    • Demand for Non-invasive Diagnostic Solutions in Critical Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Critical Care Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Immunoproteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Immunoproteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Immunoproteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Coagulation Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Coagulation Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Coagulation Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Critical Care Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Routine & Special Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Routine & Special Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Routine & Special Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Microbial & Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Microbial & Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Microbial & Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • JAPAN
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • CHINA
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • EUROPE
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Critical Care Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • FRANCE
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: France 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • GERMANY
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 47: Germany Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Germany Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Germany 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Italy 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 53: UK Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: UK Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: UK 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 56: Spain Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Spain Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Spain 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 59: Russia Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Russia Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Russia 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of Europe Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Rest of Europe 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Critical Care Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Asia-Pacific 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Asia-Pacific 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 71: Australia Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Australia Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Australia 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • INDIA
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 74: India Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: India Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: India 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 77: South Korea Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: South Korea Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: South Korea 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Asia-Pacific Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Asia-Pacific 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Critical Care Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Latin America 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 86: Latin America Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Latin America Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Latin America 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 89: Argentina Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Argentina Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Argentina 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 92: Brazil Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Brazil Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Brazil 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 95: Mexico Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Mexico Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Mexico 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 98: Rest of Latin America Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Latin America Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Latin America 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Critical Care Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Critical Care Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Middle East 16-Year Perspective for Critical Care Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 104: Middle East Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Middle East Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Middle East 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 107: Iran Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Iran Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Iran 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 110: Israel Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Israel Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Israel 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 113: Saudi Arabia Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Saudi Arabia Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Saudi Arabia 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 116: UAE Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UAE Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UAE 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 119: Rest of Middle East Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Middle East Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Middle East 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030
  • AFRICA
    • Critical Care Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 122: Africa Recent Past, Current & Future Analysis for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Africa Historic Review for Critical Care Diagnostics by Segment - Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Africa 16-Year Perspective for Critical Care Diagnostics by Segment - Percentage Breakdown of Value Sales for Immunoproteins, Routine & Special Chemistry, Hematology, Microbial & Infectious Diseases, Coagulation Test, Flow Cytometry and Other Segments for the Years 2014, 2024 & 2030

IV. COMPETITION